The Artificial Intelligence (AI) Market in Respiratory Diseases is Set to Experience Steady Growth at a 5% CAGR - EIN Presswire

AI tools for diagnosing and treating respiratory diseases are expected to grow steadily in the market. This could eventually improve care for asthma, COPD, and other lung conditions.